IMM 1.64% 30.0¢ immutep limited

the next dendreon?- a critical analysis, page-10

  1. 5,939 Posts.
    lightbulb Created with Sketch. 3
    No worries at all Psychiatrist.

    It's going to be a big week for Dendreon and the world of Immunotherapy.

    The Dendreon doubters are now few and far between.

    Prima is well positioned for a re-rating!
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.